TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Taubert medicin AB
Closing information (x1000 SEK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover | 1,859 | 1,055 | 202 |
Financial expenses | 1 | 1 | 0 |
Earnings before taxes | 130 | 33 | -74 |
EBITDA | 130 | 34 | -74 |
Total assets | 421 | 293 | 129 |
Current assets | 421 | 293 | 129 |
Current liabilities | 250 | 213 | 99 |
Equity capital | 165 | 63 | 30 |
- share capital | 50 | 50 | 50 |
Employees (average) | 2 | 2 | 1 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency | 39.2% | 21.5% | 23.3% |
Turnover per employee | 930 | 528 | 202 |
Profit as a percentage of turnover | 7.0% | 3.1% | -36.6% |
Return on assets (ROA) | 31.1% | 11.6% | -57.4% |
Current ratio | 168.4% | 137.6% | 130.3% |
Return on equity (ROE) | 78.8% | 52.4% | -246.7% |
Change turnover | 804 | 853 | -70 |
Change turnover % | 76% | 422% | -26% |
Chg. No. of employees | 0 | 1 | 1 |
Chg. No. of employees % | 0% | 100% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.